文献速递心外重症与机械循环支持肺外科食管与纵隔外科

胸廓肿瘤患者的体外膜氧合治疗:体外生命支持组织(ELSO)登记数据分析

Extracorporeal Membrane Oxygenation for Patients With Thoracic Neoplasms: An Extracorporeal Life Support Organization (ELSO) Registry Analysis.
PubMed 文献 · Ann Thorac Surg · 2022-03-26

本研究基于ELSO登记数据,纳入2000至2019年间498例成人胸廓肿瘤患者,分析其ECMO治疗结局。上气道肿瘤患者生存率较高(73.5%),而肺部肿瘤患者生存率较低(30.0%),与所有成人ECMO运行相比差异有统计学意义;气管手术后ECMO生存率较好(66.7%),而全肺切除(13.3%)、任何类型肺切除(23.7%)及食管手术(21.4%)后生存率较差。作者认为胸廓肿瘤患者ECMO结局因肿瘤亚型和相关手术类型而异,临床医生应注重个体化患者选择。

要点

  • 498例胸廓肿瘤患者ECMO出院生存率为39.8%。
  • 上气道肿瘤生存率73.5%(P=.005),肺部肿瘤生存率30.0%(P<.001)。
  • 全肺切除后ECMO生存率13.3%,任何肺切除后23.7%,食管手术后21.4%。

核心结论

  • 胸廓肿瘤患者ECMO结局因肿瘤亚型和相关手术类型等临床因素而异,临床医生应继续注重个体化患者选择以获得最佳结果。

研究设计与样本

  • 回顾性登记数据分析,查询体外生命支持组织(ELSO)登记库中2000至2019年间年龄大于18岁且国际疾病分类编码为胸廓肿瘤的患者,分析结局及包括相关手术在内的临床数据。

主要发现

  • 共498例患者符合纳入标准,198例存活至出院(39.8%)。
  • 肿瘤类型包括上气道34例、肺247例、未特指呼吸道45例、胸膜4例、心脏19例、纵隔40例、食管108例、未特指1例。
  • 与所有成人ECMO运行相比,上气道肿瘤与较好生存相关(73.5%;P=.005),肺部肿瘤与较差生存相关(30.0%;P<.001)。
  • 498例中94例(18.9%)在胸廓或气道手术后开始ECMO。
  • 气管手术后生存较好(66.7%[n=9]),而全肺切除(13.3%[n=30])、任何类型肺切除(23.7%[n=76])和食管手术(21.4%[n=14])后生存较差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Extracorporeal membrane oxygenation (ECMO) is used in the management of severe cardiopulmonary failure, but the indication in the oncologic population has not been clearly established. Among malignant neoplasms, thoracic neoplasms are unique in their potential direct impact on cardiopulmonary function. This study aimed to better define the role of ECMO for thoracic neoplasms. METHODS: The Extracorporeal Life Support Organization registry was queried for patients older than 18 years with an International Classification of Diseases code of thoracic neoplasm during the past 2 decades (2000-2019). Outcomes and clinical data including associated procedures were analyzed. RESULTS: There were 498 patients who met inclusion criteria. The neoplasms included 34 upper airway, 247 lung, 45 unspecified respiratory tract, 4 pleura, 19 heart, 40 mediastinum, 108 esophagus, and 1 unspecified; 198 patients survived to discharge (39.8%; "survival"). Upper airway neoplasms were associated with better survival (73.5%; P = .005), whereas lung neoplasms were associated with worse survival (30.0%; P < .001) compared with all adult ECMO runs. Of the 498 cases, 94 (18.9%) were started after thoracic or airway procedures. Favorable survival was associated with tracheal procedures (66.7% [n = 9]), whereas poor survival was seen with pneumonectomy (13.3% [n = 30]), any type of lung resection (23.7% [n = 76]), and esophageal procedures (21.4% [n = 14]). CONCLUSIONS: The outcome for ECMO among patients with a thoracic neoplasm is variable, depending on clinical factors including tumor subtype and type of associated procedure. Clinicians should continue to focus on individualized patient selection to achieve optimal results.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Suzuki Y, Cass S, Lentz Carvalho J, et al. Extracorporeal Membrane Oxygenation for Patients With Thoracic Neoplasms: An Extracorporeal Life Support Organization (ELSO) Registry Analysis. Ann Thorac Surg. 2022. PMID: 35351418. doi:10.1016/j.athoracsur.2022.03.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。